Regeneron to Highlight Pioneering Pipeline Progress Across Multiple Modalities Spanning 10 Types of Blood Cancers and Disorders at ASH - Regeneron Pharmaceuticals ( NASDAQ:REGN )
TARRYTOWN, N.Y., Nov. 13, 2024 ( GLOBE NEWSWIRE ) -- Regeneron Pharmaceuticals, Inc.
| Ticker |
Sentiment |
Impact |
|
REGN
|
Neutral
|
14 %
|
|
META
|
Somewhat Bullish
|
4 %
|
